The aim was to study the influence of temperature on the transport of the hepatobiliary contrast agent Gadobenate dimeglumine (Gd-BOPTA). Rat livers were isolated and perfused with Gd-BOPTA at 12, 25, 30, 36 and 38 1C. After the perfusion period, biopsies were collected and the MR signal intensity was measured. Uptake and biliary excretion were quantified with radiolabeled Gd-BOPTA. MR signal intensity decreased with temperature of perfusion. This phenomenon was appropriately quantified with 153 Gd and 153 Sm labeling, in contrast to 67 Ga.
Introduction
Gadobenate dimeglumine (Gd-BOPTA) is a new hepatobiliary contrast agent for magnetic resonance imaging (MRI). Its structure differs from the long used extracellular contrast agent gadopentetate dimeglumine (Gd-DTPA) by an additional lipophilic moiety (Fig. 1) . With this lipophilic substituent, Gd-BOPTA is taken up specifically by hepatocytes and is excreted into the bile. Consequently, Gd-BOPTA has a dual imaging capability. On the one hand, it is used as an extracellular contrast agent in the immediate postinjection phase of contrast enhancement to reveal hypervascular regions, and on the other hand, it enters into hepatocytes and facilitates MRI detection and characterization of hepatic diseases in a later delayed phase (Hamm et al., 1999; Kuwatsuru et al., 2001; Manfredi et al., 1998; Schneider et al., 2003) .
After diffusion into the extracellular space, part of Gd-BOPTA is taken up into hepatocytes and, after trafficking across the cell, is excreted into the bile without biotransformation Schuhmann-Giampieri et al., 1993) . In rats, 50% of the dose injected is excreted into the bile, the remaining being excreted into urine (De Hae¨n et al., 1996; Lorusso et al., 1999) . In contrast, only 2-7% of the dose is excreted into the bile in humans . The transport of Gd-BOPTA into hepatocytes is not fully understood. Evidence exists that Gd-BOPTA enters rat hepatocytes through a transporter belonging to the organic anion transporting polypeptide family (Oatps) localized on the sinusoidal membrane of hepatocytes (Cle´ment et al., 1998; Hahn and Saini, ARTICLE IN PRESS www.elsevier.com/locate/apradiso 0969-8043/$ -see front matter r 2004 Elsevier Ltd. All rights reserved. doi:10.1016/j.apradiso. 2004.11.002 1998; Pastor et al., 2003) . After its intracellular transport, Gd-BOPTA is eliminated into the bile through the ATP-dependent multidrug resistance-associated protein 2 (Mrp2) at the canalicular membrane of the hepatocyte (De Hae¨n et al., 1996; Pascolo et al., 2001) .
In the isolated perfused rat liver, it was shown that the increase in MR signal intensity during Gd-BOPTA perfusion can be recorded over time with a direct visualization of the absence of Gd-BOPTA entry in hepatocytes when livers were co-perfused with Gd-BOPTA and bromosulfophthalein (pharmacological inhibition) (Pastor et al., 2003) . In a hollow-fiber bioreactor containing freshly isolated rat hepatocytes, we showed that the transport of Gd-BOPTA into hepatocytes can be successfully described by compartmental analysis of the MR signal intensity recorded over time and supports the hypothesis of a transportermediated uptake (Planchamp et al., 2004a, b) .
However, information is lacking on the long-and short-term regulation of Gd-BOPTA transport in hepatocytes. Although a temperature dependence of transport through Oatps and Mrps has been previously reported (Payen et al., 2000; Ruiz-Garcia et al., 2002; Zamek-Gliszczynski et al., 2003) , its influence on the MR signal is unknown. Consequently, the aim of our study was to determine, in the isolated perfused rat liver model, the influence of temperature on Gd-BOPTA transport and its consequences on the MR signal. Because the MR signal does not allow exact quantification of Gd-BOPTA concentration in tissues, the transport of radiolabeled Gd-BOPTA was also measured.
Materials and methods

Chemicals
Gd-BOPTA was provided by Bracco Research (Geneva, Switzerland). Gd-DTPA is commercially available (Magnevist, Schering, Germany) . 153 GdCl 3 (1.0 GBq/mL) was obtained from Gamma-Service Isotopen und Strahlentechnik GmbH (Leipzig, Germany).
67
GaCl 3 (1.11 GBq/mL) was provided by Mallinckrodt (Zu¨rich, Switzerland).
153 Sm was extracted from 153 Sm-EDTMP (1.3 GBq/mL, Quadramet, Schering, Germany) as described below. All other chemicals were of analytical grade. 153 Sm-EDTMP (4 MBq) for decomplexation. Gd-DTPA and Gd-BOPTA 0.5 M solution (0.05 mL, 0.025 mmol) was added and the pH was checked. 0.1 M HCl (0.1 mL) was added before the addition of Gd-DTPA and Gd-BOPTA 0.5 M solution (0.35 mL, 0.175 mmol) if the pH exceeded 2.
Preparation of radiochemicals
Gd-DTPA and Gd-BOPTA (200 mmol) labeled with any radioisotope were mixed with Krebs-Henseleitbicarbonate (KHB) solution containing 118 mM NaCl, 1.2 mM MgSO 4 , 1.2 mM KH 2 PO 4 , 4.7 mM KCl, 26 mM NaHCO 3 , and 2.5 mM CaCl 2 (1 L, 200 mM). The presence of free ligand or free metal in the perfusion solution and in the outflow perfusate was determined by complexometry at pH 5.8, with xylenol orange as indicator (Schmitz et al., 1996) . Briefly, the radiolabeled solutions of contrast agent (0.4 mL) were mixed with a pH 5.8 buffer (10 mL) and xylenol orange indicator (0.4 mL, 0.03% w/V). A yellow color indicates the presence of a ligand excess while a violet color indicates a metal excess.
Animals
Before liver perfusion, Sprague-Dawley rats (300-450 g) were anesthetized with pentobarbital (50 mg/kg, i.p.). The protocol was approved by the animal welfare committee of the University of Geneva and the veterinary office and followed the guidelines for the care and use of laboratory animals.
Liver perfusion 2.4.1. Perfusion system
The entire perfusion system consisted of solution reservoir, pump (Ismatec, Glattbrugg-Zu¨rick, Switzerland), heating circulator (ThermoHaake DC10/P5, Switzerland), oxygenator, filter, bubble trap, and temperature probe. The livers were perfused with KHB buffer during the entire protocol with a non-recirculating perfusion. The perfusate was equilibrated in the oxygenator with a mixture of 95% O 2 -% CO 2 (2.5 L/ min) during the protocol. The temperature was measured continuously with a thermocouple thermometer (Extech Instruments Co, no 422315, Waltham, USA), the temperature probe being placed just upstream from the portal vein catheter.
Isolated perfused rat liver
Livers were perfused in situ as previously described (Pastor et al., 1996) . Briefly, the abdominal cavity was opened and the portal vein was cannulated with a G16 catheter (outer diameter: 1.8 mm) introduced into the portal vein up to 2-3 mm from the liver. A ligature was placed around the inferior vena cava above the left renal vein. After the cannulation of the portal vein, the abdominal vena cava was transected and KHB solution was pumped without delay into the portal vein. The flow rate was slowly increased over 1 min up to 30 mL/ min. In a second step, the chest was opened and a second cannula (G14) inserted through the right atrium into the thoracic inferior vena cava and secured with a ligature. Finally, the ligature around the abdominal inferior vena cava was tightened. The KHB solution was perfused to the liver through the portal catheter and eliminated by the catheter placed in the thoracic inferior vena cava. For bile collection, the common bile duct was cannulated with a PE 10 catheter. Livers were perfused with KHB solution for 15 min (recovery period) and then with KHB solution+200 mM radiolabeled contrast agent for 30 min. Outflow perfusate was collected every minute during 10 min and every 5 min during 20 min. After the 30-min perfusion period, 5 biopsies and the total bile volume were collected and the contrast agent content was determined by radioactivity measurements. The remaining liver tissue was weighed and used for MRI. During the perfusion, the liver viability was assessed by monitoring portal vein pressure (Hewlett Packard 78353B, Palo Alto, USA).
Magnetic resonance imaging
T 1 -weighted imaging of tubes containing at least 4 g of liver tissue was performed at room temperature on an Intera 1.5 T MR system (Philips Medical Systems, Cleveland, USA) using a fast field echo sequence with the following imaging parameters: saturation prepulse, TR/TE 4.3/1.3 ms, FA 801, FOV 20 cm, matrix size 96 Â 128, slice thickness 20 mm. A coil used for human head imaging was used. Mean signal intensity was measured in a circular region of interest drawn inside the tubes.
Radioactivity measurements
Radioactivity (in counts per minute) was measured in the perfusion solution (KHB+contrast agents, 1 g), the outflow perfusate (1 g), in KHB solution free of contrast agent (blank, 1 g), the bubble trap (before entry in the liver, 1 g), the bile (50 mg) and the liver biopsies (0.5-1 g) by a Packard Cobra Auto-Gamma counter (Canberra Packard, Switzerland). For concentration determinations, we assumed that density was 1 g/mL for all samples. 153 Gd]Gd-DTPA. To calculate the apparent activation energy (E a ) required for the transport of contrast agent into the bile we used a modified Arrhenius equation
where B is the amount of contrast agent excreted into the bile during 30 min, E a is the activation energy (kcal/ mol), R is the gas constant (0.001987 kcal/mol K), T (K) is the absolute temperature (1C+273), and A is the Arrhenius constant. E a is calculated from the slope of the linear regression log B ¼ f ð1=TÞ according to
Statistical analysis
Data were expressed as mean7SD. Statistical analysis was performed with a Mann-Whitney U test or with a Kruskal-Wallis test when appropriate. A P value less than 0.05 was considered statistically significant.
Results
Radioisotopes and hepatic detection of contrast agents
When livers were perfused with [
153 Gd]Gd-DTPA (200 mM, 38 1C), the concentration of Gd-DTPA in the liver was 23.372.9 mM (equal to 0.1670.02% of the perfused dose) (Fig. 2A) . The liver uptake was much higher when livers were perfused with 200 mM [ 153 Gd]Gd-BOPTA (441.6769.2 mM, i.e. 2.970.5% of the perfused dose). For both contrast agents the concentration in the outflow perfusate rapidly increased and reached a similar concentration to the perfusion solution (Fig. 2B) . However, the steady-state was significantly lower during [
153 Gd]Gd-BOPTA perfusion (18875 mM) than during [
153 Gd]Gd-DTPA perfusion (20071 mM) (P ¼ 0:046).
When contrast agents were labeled with 153 Sm, similar results were obtained (Fig. 3A) 153 Gd and 153 Sm (P ¼ 0:733). MRI of the liver biopsies confirmed that Gd-BOPTA entered into hepatocytes. The MR signal intensity was two times higher in tubes containing liver biopsies perfused with Gd-BOPTA than in those perfused with Gd-DTPA, independently of the radioisotope (Fig. 3B) . Gd. MRI of representative tubes are shown. As the liver tissue were imaged separately according to the radioisotope used, the signal intensities of Gd-BOPTA tubes were set to 100% and the signal intensities of Gd-DTPA tubes were calculated as a percentage of this value (n ¼ 3).
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The complexometry analysis indicated that there was a slight excess of ligand (yellow color) in all solutions of perfusion containing radiolabeled contrast agent and outflow perfusate. This statement excludes the presence of free metal, which might result in unspecific binding in the liver.
Temperature and Gd-BOPTA transport
When biopsies from livers perfused at various temperatures were imaged, the signal intensity declined when the perfusion temperature diminished, allowing visualization of the decreasing transport of Gd-BOPTA into hepatocytes (Fig. 4) . This finding was quantified by radioactivity measurements. At 38 1C, 2.970.5% of the amount of perfused [
153 Gd]Gd-BOPTA accumulated in the liver and 4.071.0% in the bile (Fig. 5) . In contrast, at 12 1C only 0.3070.01% was measured in the liver and no contrast agent was detected in the bile.
The logarithm of the amount of Gd-BOPTA measured in the bile was linearly correlated to the inverse function of the perfusion temperature (Fig. 5 , r ¼ 0:978; po0:005; regression equation: y ¼ 11468x þ 38). According to the slope of the linear regression (1146871412), the apparent activation energy was 52.476.5 kcal/mol for Gd-BOPTA excretion into the bile.
Discussion
Radioisotopes and hepatic detection of contrast agents
As expected, the concentration of [
153 Gd]Gd-BOPTA in the liver was more than two times higher than that in Gd-labeling, 30 mL/min) as a function of the perfusion temperature (12, 25, 30, 36 and 38 1C, mean7SD , n ¼ 3). The logarithm transformation was used to calculate the apparent activation energy (E a ) required for the transport of Gd-BOPTA into the bile according to the Arrhenius equation. the perfusion solution, indicating hepatocyte uptake of Gd-BOPTA (Fig. 2) 153 Gd]Gd-DTPA (200 mM) confirms the hepatocyte uptake of Gd-BOPTA. Such results have already been observed in a similar experimental model when 500 mM Gd-BOPTA and Gd-DTPA were perfused and measured by inductively coupled plasma atomic emission spectrometry (Pastor et al., 2003) . Thus, 153 Gd substitutes for non-radioactive Gd and consequently, [
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153 Gd]Gd-BOPTA quantification accurately reflects the transport of Gd-BOPTA into hepatocytes and the bile excretion. Although Gd-BOPTA entry in hepatocytes can be observed by MRI, the exact hepatic concentrations of contrast agents can not be quantified by signal intensity. Indeed, contrast agents acts indirectly on the MR signal by shortening the relaxation times of surrounding protons and the same concentration of contrast agents can modify the signal differently according to the binding to surrounding proteins and local microviscosity (Cavagna et al., 1997 (Pascolo et al., 1999 (Pascolo et al., , 2001 . Of note, 153 Sm also emits b À radiation whose therapeutic effects are used in cancer therapy (Serafini, 2003) and the complexation of 153 Sm with BOPTA described in our model might be a way to direct 153 Sm into hepatocytes.
As seen in Fig. 3 Ga-citrate in normal mice and in mice with tumors (Beyer et al., 1978) .
Temperature and Gd-BOPTA transport
Temperature variation modified Gd-BOPTA transport into hepatocytes and consequently the MR signal (Fig. 4) . At low temperature (12 1C), Gd-BOPTA did not enter into hepatocytes and behaved as the extracellular contrast agent Gd-DTPA. Interestingly, even a small variation of temperature from 36 to 38 1C induced changes in Gd-BOPTA transport as evidenced by the signal intensity of the Gd-BOPTA enhanced images. This observation may have clinical consequences as these temperatures correspond to values frequently measured in humans. Actually, a lower body temperature could result in a reduced uptake of Gd-BOPTA by normal hepatocytes and diminish the contrast with nonfunctioning hepatocytes that do not take up Gd-BOPTA (Kuwatsuru et al., 2001; Schneider et al., 2003) .
The apparent activation energy obtained using the Arrhenius equation was 52.6 kcal/mol for excretion of Gd-BOPTA into bile. Our results confirm the active excretion of Gd-BOPTA into bile. Indeed, high activation energies (420 kcal/mol) are commonly associated with active transport, while low activation energies are associated with passive diffusion or facilitated transport via an energy-independent carrier (Ruiz-Garcia et al., 2002) . This finding is in good agreement with the ATPdependence of the Mrp2-transporter (De Hae¨n et al., 1996; Pascolo et al., 2001) .
In contrast to the amount of Gd-BOPTA measured in the bile that depends only on biliary excretion, the amount of Gd-BOPTA in the liver depends on both liver uptake and biliary excretion. Hence, the apparent activation energy of the uptake transport could not be determined with our data.
In summary, the isolated perfused rat liver showed that radiolabeling of contrast agents is accurate and useful to quantify contrast agents transport. Labeling with radiolanthanides such as 153 Gd and 153 Sm is appropriate because 153 Gd-BOPTA and 153 Sm-BOPTA are equivalent to Gd-BOPTA, in contrast to 67 Ga-BOPTA. Uptake of Gd-BOPTA into hepatocytes and biliary excretion are highly temperature dependent with important consequences on the MR signal intensity. The lower the temperature, the lower the transport, and the lower the MR signal intensity. Thus, the regulation of Gd-BOPTA transporters is important to consider for the interpretation of the signal intensity obtained during liver imaging.
